Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2009-04-30
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interrupting Self-Harm Study
NCT03550521
Trauma Services Intervention to Prevent Violence
NCT02642224
Examining Whether Project Support Works
NCT06963554
Protect Yourself: Abuse Prevention for People With Intellectual Disabilities
NCT03998605
Restoring Emotional, Sexual, and Physical Empowerment Through CBT & Trauma-sensitive Care: A Chronic Pelvic Pain Intervention
NCT02588885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced Consent Procedure
Participants in this group will receive an enhanced consent that will be an hour longer than usual.
Enhanced consent procedure
Enhanced consent entails a more detailed consent procedure
Consent as Usual Procedure
Participants in this group will receive a normal consent procedure to the study
Consent as Usual
Routine informed consent procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced consent procedure
Enhanced consent entails a more detailed consent procedure
Consent as Usual
Routine informed consent procedures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female
* between 18-55
* experienced trauma
* willing to have a brain scan
* provide consent
Exclusion Criteria
* bipolar disorder
* suicidal intent
* metal in the body or anything else that would interfere with an MRI
* claustrophobia or inability to lie still for 45 minutes
* receiving current counseling
* on certain antidepressants, benzodiazepines, or other psychotropic medication
* pregnant or nursing
18 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgetown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Ann Dutton, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Ann Dutton, PhD
Role: PRINCIPAL_INVESTIGATOR
Georgetown University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4295-033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.